Data-Gouv-ML/pcri-informations-sur-les-projets-laureats huggingface dataset:
Bristol Bright Night (BGCN)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: European researchers' Night
Action type: Marie Skłodowska-Curie actions
Countries involved: United Kingdom,United Kingdom
Call: European Researchers' Night (NIGHT) (H2020-MSCA-NIGHT-2014, 2014)
Start date: 2014-06-01
End date: 2015-09-30
Duration (months): 16.0
Total project cost (EUR): 127855.0
EU funding (EUR): 127855.0
Participants: 3
Project status: CLOSED

Bristol’s proposal for the Marie Skłodowska-Curie Researchers’ Night programme takes part across 2014 and 2015. Bristol’s programme for Researchers’ Night has an ambition to involve a wide cross-section of researchers across the city’s two universities centred on the theme ‘Bristol Bright Night’ highlighting the innovative research undertaken by Bristol-based researchers addressing local and global societal challenges. During the Researchers’ Night the city’s waterfront will be transformed into an Innovation Laboratory giving everyone equal access to ground-breaking research, in particular young and family audiences. Bristol has the advantage of having several world-renowned public venues within a short walk of each other in its historical centre. These will host the Researchers’ Night 2014 and 2015. Additionally, in 2015 special opportunities will be provided for celebrating the 10th anniversary of the Researchers’ Night, and the programme will also benefit from Bristol’s designation as European Green Capital in 2015. Bristol’s programme for Researchers’ Night will focus on environmental science and sustainability research conducted locally and through European projects, particularly by Marie Skłodowska-Curie (MSC) fellows, however, Bristol’s digital and creative media cluster will also be involved.

Keywords: bristol,research,careers,young people
Patient-self-adaptive system for detection, recording and alert to caregivers of night-time seizures, linked to private cloud platform for patient tracking and big data exploitation. (SEIZSAFE)

Framework: Horizon 2020 — Societal Challenges
Programme: Health, demographic change and wellbeing
Theme: Active ageing and self-management of health
Action type: SME instrument
Countries involved: Spain
Call: Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well (H2020-SMEINST-2-2016-2017, 2016)
Start date: 2016-06-01
End date: 2019-02-28
Duration (months): 33.0
Total project cost (EUR): 856375.0
EU funding (EUR): 599462.5
Participants: 1
Project status: CLOSED

Approximately 50 million people worldwide have epilepsy, an illness characterized by recurrent seizures. The estimated proportion of the general population with active epilepsy is between 4 and 10 per 1000 people. Globally, an estimated 2.4 million people are diagnosed with epilepsy each year. When patients suffer generalized convulsions there is a risk for them of being injured or having a cardiac arrest. Caregivers (usually patients’ relatives) reduce this risk by being alert and applying techniques such as holding the patients, putting them in a certain stance or providing them with the prescribed drugs. The problem worsens when seizures occur at night-time. Caregivers usually sleep in the same bedroom as patients and cannot rest due to the constant concern, leading to inconveniences such as loss of privacy, bad resting and higher risk for patients. This project aims to improve the lives of people affected by epilepsy, both patients and caregivers, providing them with an effective and unobtrusive device to monitor patients and alert caregivers during night-time seizures. This project consists on a patient-self-daptive system to detect, video-record and alert caregivers of night-time seizures, linked to a private cloud platform for medical tracking of patients and big data exploitation. The main innovative characteristics of SEIZSAFE are: • Patient-self-adaptive and self-learning algorithm for seizure detection • Camera and cloud platform for doctors • Reduced-cost technology • Medical validation The present project aims to expand SEIZSAFE in the European market. Considering a global market size of 1.2M epilepsy patients suffering night-time seizures, ENCORE foresees the uptake of 6.5% of the market in 5 years, which means 80,000 users by the end of 2022.

Keywords: epileptic seizures,early detection,support for diagnosis and prescription
Regenerative Medicine Innovation Crossing - Research and Innovation Staff Exchange in Regenerative Medicine (REMIX)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Research and innovation staff exchange
Action type: Marie Skłodowska-Curie actions
Panel: Information Science and Engineering
Countries involved: Italy,Korea, Republic of,Mongolia,Thailand,Portugal
Call: Research and Innovation Staff Exchange (H2020-MSCA-RISE-2017, 2017)
Start date: 2017-11-01
End date: 2023-04-30
Duration (months): 66.0
Total project cost (EUR): 877500.0
EU funding (EUR): 670500.0
Participants: 5
Project status: SIGNED

Natural materials in biomedical field are investigated for clinical use, as materials for the fabrication of biomedical prostheses, for the stimulation of regenerative medicine patterns, or as carriers for drug release, and have acquired increasing relevance in the past years, being recognized their intrinsic bioactive properties and the possibility to repair and overcome diseases with the use of Tissue Engineering and Regenerative Medicine (TERM) based procedures. Different kinds of natural materials like silks from silkworms, chitins and chitosan from crustacean, corals, collagen from marine organisms, polymers derived from plants or algae have found or are investigated for clinical use. Research activities will be directed to the exploitation and validation of natural materials for tissue engineering applications. The exchange of faculties and researchers aims also at comparing methods, regulations, procedures, good practices and methodologies with the goal of establishing a consensus on the use of in vitro experiments for the validation of materials, the possibility of building in vitro models for the investigation and the reduction of animal testing, and the use of in vitro technologies for the construction of 3D predictive models to be used for the evaluation of biocompatibility of materials, efficacy of regenerative process and drugs efficiency without earlier use of animal testings, and to model disease progress and mechanisms (e.g. tumor models). The involved institutions have a proven excellence in the area covered by this proposal, and scientific collaborations already exist among their scientists. Besides, the two EU partners are members of the European Institute on Regenerative Medicine, with a dense network of collaborations all over the world. The exchange of researchers and the organization of joint networking activities will facilitate the know how circulation, alignment of procedures and the involvement of a broader industrial community.

Keywords: tissue engineering,regenerative medicine,scaffold,natural materials,in vitro testing
Physical principles of the creation of novel SPINtronic materials on the base of MULTIlayered metal-oxide FILMs for magnetic sensors and MRAM (SPINMULTIFILM)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Research and innovation staff exchange
Action type: Marie Skłodowska-Curie actions
Panel: Physics
Countries involved: Germany,Ukraine,Israel,Belgium,Lithuania,Belarus,Lithuania,Portugal
Call: Research and Innovation Staff Exchange (H2020-MSCA-RISE-2017, 2017)
Start date: 2018-01-01
End date: 2023-06-30
Duration (months): 66.0
Total project cost (EUR): 436500.0
EU funding (EUR): 436500.0
Participants: 8
Project status: SIGNED

The main goal of the project is the elaboration of research and development principles and technology, as well as creation of novel nanoheterostructures for application in spintronic devices, first of all, in magnetic field sensors and magnetoresistive random access memories. The key research and technological aspects are focused on the formation of layers and/or nanosized grains of a ferromagnetic material with an ultimate degree of conduction electron spin polarization, separated by dielectric interlayers. The main research, technological and innovation aspects of the work are aimed at an increase of the devices’ sensitivity to magnetic fields thanks to the high degree of spin polarization and to the magnetoresistance due to electron quantum tunneling through dielectric barriers. The proposed creation methods of the device prototypes can be rapidly implemented in the automotive, electronic and biomedical industries by means of a rather simple technology, which makes them attractive for the industry across the EU, as only the standard technological equipment is used. The new generation spintronic devices to be developed in the present project will possess high sensitivity, speed performance and low energy consumption. The project aims as well at the creation of a stimulating and interdisciplinary training partnership, with actors from the academia and private sector, promoting the exchange of ideas, methods, techniques as well as enabling an accelerated technology transfer from science to industry through a continuous collaboration between the stakeholders. Working on spintronics demands strongly innovative and interdisciplinary skills, since there is a lot of pressure from the private sector to develop new original solutions for the modern devices. Training of the high-level personnel possessing complementary interdisciplinary skills is thus a key issue.

Keywords: spintronics,nanoheterostructures,tunneling magnetoresistance,strontium ferromolybdate
INcreasing the InNOVation Management Capacity of SMEs in ISTanbul 2.0 (INNOVIST 2.0)

Framework: Horizon 2020 — Industrial Leadership
Programme: Innovation in SMEs
Action type: Specific Grant agreement
Countries involved: Türkiye
Call: H2020 2D CONSULTATION EEN (H2020-EEN-SGA2-2017-2018, 2016)
Start date: 2017-01-01
End date: 2018-12-31
Duration (months): 24.0
Total project cost (EUR): 231335.0
EU funding (EUR): 231334.0
Participants: 3
Project status: CLOSED

INNOVIST 2.0 aims to provide Key Account Management (KAM) services to beneficiaries of Horizon 2020’s SME Instrument and providing services for “Enhancing Innovation Management Capacity” (EIMC) to SMEs in the Istanbul region. The main objective of the project is to contribute to enhancing the competitiveness, growth and profitability of SMEs in the region by assessing their innovation management capacities, performing gap analyses, and developing and prioritizing actions to resolve problems and further improve their innovation outcomes. The innovation management capacity and performance of a company will be assessed by using tools in compliance with the CEN/TS 16555-1 standard (such as IMP3rove or smE-MPOWER). A total of 115 SMEs will be provided this service, 105 of them targeted for EIMC services (7-10 days long), and 10 reserved for KAM services. The consortium will devote 1,8 FTE for these services for the 2017-2018 period.

Keywords: innovation management,innovation management capacity,assessment tool,sme instrument,key account management,innovation strategy
Condensed-phase Optical-Femtosecond-Fringe-Encoded EUV Diffraction (COFFEE)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Individual Fellowships (IF)-Standard European Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Physics
Countries involved: Austria
Call: Marie Skłodowska-Curie Individual Fellowships (IF-EF) (H2020-MSCA-IF-2014, 2014)
Start date: 2015-04-01
End date: 2017-03-31
Duration (months): 24.0
Total project cost (EUR): 166156.8
EU funding (EUR): 166156.8
Participants: 1
Project status: CLOSED

As can be seen in the history of science, new techniques and methods open new research fields. In this project, the authors propose to use a new methodology approach to study thin layers of condensed matter and surfaces. We aim to perform Attosecond Transient Absorption Spectroscopy combined with femtosecond Transient Grating to study ultrafast time evolution of a model sample – solid krypton. We identify our major objectives as work packages: WP1: Attosecond XUV Transient Absorption Spectroscopy of gaseous krypton. WP2: Attosecond XUV Transient Absorption Spectroscopy in the condensed phase, the example of solid krypton. WP3: Condensed phase Transient Grating spectroscopy in the XUV spectral range with attosecond resolution. All experiments will be performed by O. Hort PhD within the Ultrafast Laser Group led by Prof. A. Baltuška (Photonics Institute, the Vienna University of Technology, Austria).

Keywords: attosecond transient absorption spectroscopy,transient grating,few cycle pulses,solid krypton,ac stark shift
The King’s City: A Comparative Study of Royal Patronage in Assur, Nineveh, and Babylon in the First Millennium BCE (RoyalCities)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Individual Fellowships (IF)-Standard European Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Social Sciences and Humanities
Countries involved: Austria
Call: Individual Fellowships (H2020-MSCA-IF-2016, 2016)
Start date: 2018-09-01
End date: 2020-08-31
Duration (months): 24.0
Total project cost (EUR): 166156.8
EU funding (EUR): 166156.8
Participants: 1
Project status: CLOSED

Cities first developed in the fourth millennium BCE in Mesopotamia and quickly became the centers of civilization. Despite extensive work on urban landscapes from an archaeological perspective, these ancient cities remain poorly understood. Even less studied are royal capitals, the seats of kingship when empires emerged in the first millennium BCE. This project explores capitals from the two main, competing empires—Neo-Assyrian and Neo-Babylonian—to address key questions: what constitutes a royal capital and what distinguishes it from other important cities? How are capitals conceptualized by the kings who inhabit, establish, and renovate them? What are the effects of the kings’ presence in and patronage of the capital cities on the urban fabric and the social and economic structure of the urban population? By juxtaposing the Assyrian capitals in Assur and Nineveh with the Babylonian capital of Babylon as case studies, this research uses a novel comparative approach based on a methodology that combines philology, religious studies, and social and political history to answer these questions. Uniting materials from the highest levels of state such as royal inscriptions, decrees, and letters with administrative, economic, and private archives, and joining these textual records with archaeological evidence through the lens of royal patronage, this project employs an innovative holistic and interdisciplinary framework to reveal how the kings’ ideological and official relationships to their capitals affects the social and bureaucratic structures of these cities. The project capitalizes on the knowledge transfer between the researcher’s Neo-Assyrian specialty and the host institution’s Neo-Babylonian expertise. The project’s results have great potential to revolutionize our understanding of cities and royal power in the ancient world, and to make accessible a wealth of new data for fields as diverse as history, anthropology, sociology, urban studies, and political science.

Keywords: assyria,babylonia,mesopotamia,capital cities,royal patronage
Ultra-small implanted neurostimulation device for the treatment of Obstructive Sleep Apnea (Nyxoah)

Framework: Horizon 2020 — Societal Challenges
Programme: Health, demographic change and wellbeing
Theme: Active ageing and self-management of health
Action type: SME instrument
Countries involved: Belgium
Call: Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well (H2020-SMEINST-1-2016-2017, 2016)
Start date: 2016-06-01
End date: 2016-09-30
Duration (months): 4.0
Total project cost (EUR): 71429.0
EU funding (EUR): 50000.0
Participants: 1
Project status: CLOSED

Obstructive Sleep Apnea is the world's most common sleep disorder and affects 100m people worldwide. It is particularly prevalent among elderly and obese cohorts and is a lifelong disease, with acute and chronic health impacts. It is linked to increased cardiovascular morbidity and mortality, and associated with increased risk of heart attack, cardiac arrhythmia, stroke, daytime sleepiness, depression and poor neurocognitive performance. Estimated annual economic costs of the disease are €60-150b. Established therapeutic options are uncomfortable with unpleasant side effects and/or ineffective; they can also require invasive surgery. Compliance is a major problem with the first line treatment, CPAP: 50% of users refuse it outright or fail to continue use after 1 year. Nyxoah's disruptive neurostimulation device responds directly to these needs and drawbacks. Central to the system is a tiny device implanted under the chin that - compared to other neurostimulator implantations - is smaller, less invasive and has lower risk of infection. The device is powered wirelessly by an activation chip, which is attached to a disposable smart patch and stuck under the chin before sleep. No mask, no noisy machine, no unpleasant side effects. The chip has a closed feedback loop with the implant, which detects tissue resistance and tells the chip to adjust the pulse to keep constant pressure on the nerve, to avoid burnout; it also communicates wirelessly with an app, which displays useful information (synced with the cloud) for use by patients, physicians and social security agencies; this is a key development to allow treatment compliance monitoring and therefore for reimbursement. During the Phase 1 project, the company, founded in 2009, will assess scale-up industrialization plan, product development according to regualatory standards and clinical trials to be deployed in Europe to show the system efficacy on patient outcome and public healthcare costs.

Keywords: apnea,sleep apnea,sleep disorder,neurostimulation,surgery,wireless,wearable,portable,obstructive sleep apnea,healthcare,wellbeing,medical device
Using Nano-Magnetic Resonance to deliver the world’s most cost-efficient system for the treatment of toxic industrial and landfill wastewater (NMRT)

Framework: Horizon 2020 — Industrial Leadership
Programme: Innovation in SMEs
Action type: SME instrument
Countries involved: Portugal
Call: SME instrument (H2020-SMEInst-2018-2020-1, 2018)
Start date: 2019-01-01
End date: 2019-06-30
Duration (months): 6.0
Total project cost (EUR): 71429.0
EU funding (EUR): 50000.0
Participants: 1
Project status: CLOSED

The NMRT project aims at rolling to market a disruptive technology that uses electromagnetic resonance to treat wastewater, producing inert flocculates as a biproduct. The current TRL 6 prototype has been successfully tested in different kinds of wastewater (winery, landfill, leachate, tannery and textile industries), with two valid independent laboratory analyses to confirm it. Our fist paid pilot is running since June 2018 with great results. NMRT has competitive installation costs (CAPEX - for both new wastewater treatment plants and as a secondary and tertiary system retrofitted in existing facilities) and has low maintenance and energy costs (OPEX), with no need for chemicals (compared to current best available technologies, such as reverse osmosis). Difficulties in reaching full compliance with EU water directives such as the Urban Wastewater Treatment Directive include high investment needs, mobilisation of the necessary funding, long and complex procedures for creating new infrastructure and for improving existing ones. NMRT is an innovative electromagnetic resonance treatment that specifically targets the pollutants that need to be eliminated before water can be reused for irrigation or groundwater discharge. Our project aligns completely with wastewater challenges identified by EU directives and legislation and H2020 objectives. We aim at demonstrating NMRT at a large-scale plant, and will make use of the Phase 1 project to prepare a detailed feasibility study to confirm the viability of our solution and gather potential client feedback and willingness-to-buy. FUNCIONAL is a European start-up created in 2016 specifically to bring NMRT technology to the market, and our consulting services and small-scale treatment plants have generated a turnover of 100.000€ in 2017. Our CEO has over 15 years of entrepreneurship experience, our Head of RDI is a waster water expert with 25 years of experience and our Head of Sales has 30 years of commercialization expertise.

Keywords: wastewater treatment system,leachate,electromagnetic treatment process
Non-covalent photoresponsive tags for photoacoustic imaging: Giving voice to living matter (SmartSAST)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Individual Fellowships (IF)-Standard European Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Chemistry
Countries involved: France
Call: Individual Fellowships (H2020-MSCA-IF-2019, 2019)
Start date: 2020-04-01
End date: 2022-03-31
Duration (months): 24.0
Total project cost (EUR): 184707.84
EU funding (EUR): 184707.84
Participants: 1
Project status: CLOSED

Visualizing the complexity of living matter non-invasively and with high-resolution represents an indispensable element for progress in science. Unresolved issues as the individuation of early-stage cancers, or the spatial organization of the roots microbiomes, can benefit from advancements in photoacoustic imaging (PAI). This appealing technology combines the benefits of light as input and ultrasounds as output, offering a compelling combination of good resolution, high penetration depth, and non-invasiveness. However, PAI is not suitable to study multicomponent living systems because current strategies operate with simple probe-detector setups. With SmartSAST (Smart Sound-activated Absorption Shifting Tags), I propose to enable modularity and multiplexing through the development of photoacoustic probes based on protein tags that non-covalently bind with photoresponsive organic chromophores named sonogens. The supramolecular nature of SmartSAST ensures great modularity as the sonogens can be easily refreshed or substituted. The change in optical properties of the probes upon assembly guarantees great contrast against the background. Finally, via rationally designing photo-isomerizable sonogens that bind the protein just in a specific isomeric form, SmartSAST imparts an unprecedented level of control in PAI. Upon photo-modulating the supramolecular dynamics of these probes and extracting their kinetic signatures, dynamic contrast and multiplexing will be achieved with high spatial resolution. SmartSAST project aims to develop a fully operative technology based on new fundamentals bases. The project includes the synthesis of sonogens, the engineering of protein tags, the thermokinetic and photochemical characterization of the probes and their application in PAI. This new approach to PAI will unlock the non-invasive study of deeply embedded complex biological targets in real-time. Dissemination and communication activities will secure the great impact of SmartSAST.

Keywords: photoswitchable tags,protein tags,supramolecular strategies,photoacoustic imaging,dynamic contrast